ABI
ABT icon

Adamant Biomedical Investments’s Abbott ABT Stock Holding History

Adamant Biomedical Investments’s Portfolio ABT Stock Details ABT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$7.79M Sell
173,000
-27,000
-14% -$1.18M 1.86% 16
2014
Q3 		$8.32M Buy
+200,000
New +$8.46M 2.08% 12

Other funds holding ABT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Adamant Biomedical Investments's ABT Position: Q4 2014 in Review

Adamant Biomedical Investments reduced its Abbott (ABT) stake by 14% in Q4 2014, selling an estimated $1.18M and leaving 173,000 shares worth $7.79M. The position accounts for 1.86% of the portfolio, ranked #16.

Adamant Biomedical Investments first reported a position in ABT in Q3 2014 and has held it in 2 quarters since. The position peaked at $8.32M in Q3 2014. 1,481 funds tracked by Wall St. Rank hold ABT as of Q4 2014.

  • Adamant Biomedical Investments held 173,000 shares of Abbott worth $7.79M as of Q4 2014.
  • Adamant Biomedical Investments sold 27,000 Abbott shares in Q4 2014, an estimated $1.18M.
  • Abbott made up 1.86% of Adamant Biomedical Investments's portfolio in Q4 2014, its #16 holding.
  • Adamant Biomedical Investments first reported a position in Abbott in Q3 2014 and has held it in 2 quarters since.
  • Adamant Biomedical Investments's Abbott position peaked at $8.32M in Q3 2014.
  • 1,481 funds tracked by Wall St. Rank held Abbott as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.